LZ enters today's Q1 print at $6.28, down 6.4% on the day and off nearly 3% on the week — though the stock has clawed back 7.7% over the past month. That recovery sits against a backdrop where analyst sentiment has deteriorated sharply and short sellers retain a meaningful position.
Short interest accounts for 7% of the free float — elevated enough to matter, though it has been falling. The position shrank 16.8% over the past month, as bears gradually covered. Borrow costs are negligible at 0.48% annualised, and availability remains loose, meaning the lending market puts no squeeze pressure on the remaining shorts. The ORTEX short score of 51.6 sits in mid-range, consistent with a position that is present but not intensifying. Options positioning is equally neutral: the put/call ratio of 0.61 is almost exactly in line with its 20-day average of 0.62, with a z-score close to zero. Neither the options nor the lending market flashes unusual anxiety ahead of the print.
The analyst picture is the more pointed signal. The most recent action came from Barclays in early March, when the desk downgraded LZ to Underweight and cut its target from $9 to $6 — a meaningful move by a bellwether firm, and one that framed the stock as having limited near-term catalysts. The broader analyst panel reflects the same caution: the consensus sits at hold, with four hold ratings and one underperform. The mean price target of $8.71 implies roughly 39% upside from current levels, but that figure is anchored by stale data from firms that have yet to update since the February earnings miss, which sent the stock down 11.6% in a single session. JP Morgan maintained an Overweight at $11 back in February, but that note predates the Q4 reaction and may reflect a more optimistic base case than the current setup warrants. Bears point to a 29% year-over-year drop in website traffic and a projected decline in business formations, both headwinds for LZ's subscription and one-time legal services revenue. Bulls argue the broader surge in business applications — up 31% year-over-year in April — supports structural demand for LZ's services. The two camps are reading different indicators of the same underlying trend in small business formation.
BlackRock and Goldman Sachs Asset Management both added meaningfully to their positions through Q1, with BlackRock adding over 7 million shares and Goldman nearly 2.3 million. Those additions suggest at least some institutional conviction remains, even as CFO Noel Watson and Chairman/CEO Jeffrey Stibel sold shares in February — routine in structure but worth noting given the stock's proximity to multi-year lows.
The print will therefore test whether LZ's subscription revenue has stabilised after the Q4 stumble, and whether management can offer any credible signal on traffic recovery — the metric that most divides the current bull and bear debate.
See the live data behind this article on ORTEX.
Open LZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
